Related Experiment Video
Updated: Jun 21, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
circPCMTD1 : A protein-coding circular RNA that regulates DNA damage response in BCR/ABL -positive leukemias
Circular RNA circPCMTD1 drives leukemia cell growth by enhancing DNA damage tolerance. Inhibiting circPCMTD1 in BCR-ABL positive leukemia prolongs survival by disrupting this protective mechanism.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Circular RNAs (circRNAs) are emerging regulators of cellular processes, implicated in various diseases.
- The role of specific circRNAs, like circPCMTD1, in acute leukemias remains largely unexplored.
Purpose of the Study:
- To investigate the functional significance of circPCMTD1 in acute leukemias, particularly those with BCR-ABL translocations.
- To elucidate the molecular mechanisms by which circPCMTD1 influences leukemic cell behavior and survival.
Main Methods:
- Screening experiments to assess the impact of circPCMTD1 depletion on leukemic cell proliferation.
- Mass cytometry to identify downstream cellular events following circPCMTD1 modulation.
- In vivo studies using mouse models engrafted with human leukemic cells.
- Mechanistic investigations involving subcellular localization, ribosome association, and peptide product analysis.
Main Results:
- Depletion of circPCMTD1 significantly inhibited the proliferation of BCR-ABL-positive leukemic cells.
- circPCMTD1 depletion triggered an aberrant DNA damage response in leukemic cells.
- Targeting circPCMTD1 in vivo prolonged the survival of mice with Philadelphia chromosome-positive leukemia.
- circPCMTD1 was found to generate a peptide that enhances the BTR complex, increasing tolerance to genotoxic stress.
Conclusions:
- circPCMTD1 plays a critical role in promoting the proliferation and survival of acute leukemia cells, especially those with BCR-ABL.
- The circPCMTD1-derived peptide confers tolerance to genotoxic stress by modulating the BTR complex.
- circPCMTD1 represents a potential therapeutic target for acute leukemias harboring the Philadelphia chromosome.
More Related Videos
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Anaphase Promoting Complex
Targeted Cancer Therapies
There are several types of targeted therapies against...